# Valion Bio (VBIO) — Overview

VBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vbio

## Price

Last close $1.23 on Oct 15, 2026. 52-week range $1.23 – $75.25.

## Company profile

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$7.1M |
| Net income growth (year over year) | -267.84% |
| Net margin | 0.00% |
| Return on equity | -240.82% |
| EPS (trailing twelve months) | −$117.95 |
| Book value per share | $71.56 |
| P/E (trailing twelve months) | — |
| Price to book | 0.2 |
| Debt to assets | 63.40% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in Valion Bio (VBIO)?

VBIO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).